IT Helpdesk Technician

Position Overview: We are seeking a highly skilled IT Helpdesk Technician with deep expertise in macOS , windows (workstation + server ) & iOS technologies to provide premium technical support to users. This role requires excellent problem-solving skills, a customer-first attitude, and a keen ability to manage and resolve technical issues swiftly and professionally. In addition to the above technologies , the ideal candidate should be experienced in supporting enterprise applications like Microsoft 365, collaboration tools, and endpoint management solutions such as Zoom, Logitech Collab OS, NinjaOne, and Intune. This position occasionally requires on-call availability and working outside regular hours to provide support to the users and the executive team., * Provide white-glove, concierge-level technical support to executive-level staff and VIP users.

• Troubleshoot and resolve hardware, software, and connectivity issues on Windows, macOS and iOS devices.
• Manage and support enterprise applications including Microsoft 365, Teams, Outlook, and SharePoint.
• Ensure timely resolution of technical issues through efficient diagnosis and problem-solving.
• Provide support for video conferencing and collaboration platforms such as Zoom, MS Teams and Logitech Collab OS.
• Utilize NinjaOne for remote monitoring and management of devices.
• Provide training and guidance to executives on the optimal use of technology.
• Document incidents, issues, and solutions using the company's ticketing system.
• Collaborate with other IT team members and vendors to escalate and resolve complex issues.
• Manage hardware inventory and coordinate repairs or replacements as necessary.
• Maintain a high level of professionalism and confidentiality when handling sensitive information.

• Proven experience as an IT Helpdesk Technician or similar role.
• Extensive knowledge of Apple hardware, software, and device management solutions.
• Strong understanding of Microsoft 365 applications and services.
• Experience supporting collaboration tools such as Zoom and Logitech Collab OS.
• Experience with remote management and monitoring tools such as NinjaOne.
• Experience with mobile device management solutions, particularly Intune.
• Familiarity with networking concepts (TCP/IP, DNS, VPNs) and troubleshooting.
• Excellent communication and interpersonal skills, with a customer-service mindset.
• Ability to handle high-pressure situations with professionalism and discretion.
• IT certifications (e.g., Apple Certified Support Professional, Microsoft 365 Certified) are preferred.

Preferred Skills:

• Experience providing direct support to C-level executives or senior management.
• Knowledge of ITIL framework and best practices.
• Familiarity with remote support tools and enterprise ticketing systems (e.g. Freshservice).

Education:

• Bachelor's degree in information technology, Computer Science, or a related field preferred, or equivalent experience.

The hourly pay range for this position at commencement of employment is expected to be between $60/hour and $75/ hour however, pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. The Company's proprietary peptide technology platform enables de novo discovery of peptide therapeutics. Two novel peptides derived from Protagonist's proprietary discovery platform are at or near commercialization. ICOTYDE (icotrokinra) is approved in the U.S. for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy. ICOTYDE is the first and only targeted oral peptide that precisely blocks the Interleukin-23 receptor (IL-23R) licensed to Janssen Biotech, Inc.,a Johnson & Johnson company. ICOTYDE was jointly discovered by Protagonist and Johnson & Johnson scientists, with Protagonist having primary responsibility for the development of ICOTYDE through Phase 1, and Johnson & Johnson assuming responsibility for further development and commercialization. An NDA for rusfertide, a first-in-class hepcidin mimetic peptide that is being co-developed with Takeda Pharmaceuticals pursuant to a worldwide license and collaboration agreement entered in 2024, is under priority review with the FDA. Protagonist holds an option to co-commercialize rusfertide in the U.S. through a 50/50 profit and loss share structure or can opt-out of this structure. The Company also has a number of preclinical stage drug discovery programs addressing clinically and commercially validated targets including an oral IL-17 peptide antagonist, obesity dual and triple agonists, an oral hepcidin functional mimetic, and the recently announced IL-4 and amylin programs.